-
Mechanisms_of_patient_response_to_Dabrafenib_in_Melanoma
Study
EGAS00001000946
-
The Precision Medicine in Liver Cancer across an Asia-pacific NETwork (PLANET) - Intratumoural immune heterogeneity
Study
EGAS00001003814
-
Tumor transcriptome profiling from the OAK and POPLAR randomized clinical trials of atezolizumab in 2L NSCLC
Dataset
EGAD00001007703
-
Single-cell profiling of neoantigen-specific T cells in lung cancers treated with neoadjuvant PD-1 blockade
Dataset
EGAD00001007728
-
Integrated genomic analysis identifies driver genes and cisplatin-resistant progenitor phenotype in pediatric liver cancer
Dataset
EGAD00001007858
-
eMERGE Network's Multi-Center Pilot of Pharmacogenetic Sequencing in Clinical Practice
Study
phs000906
-
PSCP_bisulphite_analysis_in_hESCs
Study
EGAS00001001625
-
PSCP_mutation_analysis_in_hESCs
Study
EGAS00001001561
-
RNA_seq_analysis_of_transcriptome_variation_with_human_ESC_subclones
Study
EGAS00001001655
-
CCDG CVD: VIRGO - Variation in Recover-Role of Gender on Outcomes of Young Acute Myocardial Infarction (AMI) Patients
Study
phs001259
-
African American Multiple Myeloma GWAS
Study
phs001632
-
TNBC ctDNA Targeted Panel
Study
EGAS00001006937
-
Genomic_characterisation_of_MGUS__
Study
EGAS00001004124
-
Dissection of the molecular complexity of colorectal cancer in pre-clinical models identifies predictive signatures of sensitivity to EGFR inhibitors
Study
EGAS00001001752
-
The genomic basis of childhood T-lineage acute lymphoblastic leukemia
Study
EGAS50000000016
-
Dataset for Sarcoma RNA sequencing linked from study EGAS00001004813
Dataset
EGAD00001010276
-
National Human Genome Research Institute (NHGRI) GENEVA Genome-Wide Association Study of Venous Thrombosis (GWAS of VTE)
Study
phs000289
-
Neoantigen-Targeted CD8+ T-Cell Responses 1 With PD-1 Blockade Therapy
Study
phs003153
-
The genomic complexity of early T-cell progenitor acute lymphoblastic leukemia
Study
phs000340
-
Disorders/Differences of Sex Development (DSD) Study Performed at UCLA in Collaboration with the DSD-Translational Research Network (DSD-TRN), with the Support of the Gabriella Miller Kids First Pediatric Research Program
Study
phs001178
-
Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response In Vivo
Study
phs002334
-
PSCP_bisulphite analysis in hESCs (2018-08-13)
Dataset
EGAD00001004295
-
PSCP_mutation analysis in hESCs
Dataset
EGAD00001002231
-
PSCP_bisulphite analysis in hESCs
Dataset
EGAD00001002235
-
OpACIN-neo – A Multicenter Phase 2 Study to identify the Optimal neo-Adjuvant Combination scheme of Ipilimumab and Nivolumab – RNA sequencing
Study
EGAS00001004833
-
Blood Somatic Mutations in TCGA Donors Suffering from Solid Tumors
Study
phs002867
-
Small_molecule_inhibitors_in_melanoma___Kenski___Kong___WES
Study
EGAS00001002863
-
Chromothripsis in human breast cancer (HIPO K26K/H017/A017)
Study
EGAS00001004662
-
RNASeq of Plasmacytoid Dendritic Cells in Head and Neck Squamous Cell Cancer Patients
Study
phs001824
-
Liquid biopsy for molecular characterization of diffuse large B-cell lymphoma and early assessment of minimal residual disease
Study
EGAS50000000215
-
Impact of Respiratory Virus Infections and Bacterial Microbiome Shifts on Lymphocyte and Respiratory Function in Infants Born Prematurely or Full Term
Study
phs001347
-
Defining T cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Study
phs001680
-
Predictive value of chromosome 18q11.2-q12.1 loss for benefit from bevacizumab in metastatic colorectal cancer; a post-hoc analysis of the randomized controlled trial AGITG-MAX
Study
EGAS00001005453
-
Germline variants collaborate with somatic mutations and initiate and/or drive disease in primary myelodysplastic syndrome (MDS) and therapy-related myeloid neoplasms (t-MN)
Study
EGAS00001003547
-
Demographically Diverse Substance Use Disorder Cohorts of Dr. Stanley H. Weiss
Study
phs002140
-
ALCHEMIST Study
Study
phs001140
-
International Standards for Cytogenomic Arrays
Study
phs000205
-
Implementation of pediatric precision oncology into clinical practice: The individualized Therapies for Children with cancer program “iTHER”
Study
EGAS00001007099
-
Breast cancer DNA repair
Study
EGAS00001002792
-
High-Resolution Clonal Mapping of Multi-Organ Metastasis, and Resistance to Neoadjuvant Chemotherapy, in Triple Negative Breast Cancer
Study
phs001742
-
Myeloma Genome Project Targeted Panel Validation dataset
Dataset
EGAD00001008689
-
Clonal selection after gene therapy in sickle cell disease
Dataset
EGAD00001010913
-
Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia
Study
EGAS50000000106
-
Biomarker Screen for Efficacy of Oncolytic Virotherapy in Patient-derived Pancreatic Cancer Cultures
Study
EGAS00001007001
-
Intra-tumor heterogeneity and clonal evolution patterns towards platinum-resistant high-grade serous ovarian cancer
Study
EGAS00001001244
-
Analysis of RAD51C promoter methylation using targeted bisulfite sequencing (amplicon sequencing) in ovarian cancer pre-clinical models and patient samples.
Study
EGAS00001005395
-
Proteom characterization in primary colorectal cancer and corresponding liver metastasis
Study
EGAS00001005641
-
EPICC: Evolutionary Predictions in Colorectal Cancer WGS-3
Dataset
EGAD00001008642
-
Hepatitis C Antiviral Long-term Treatment Against Cirrhosis (HALT-C)
Study
phs000430
-
Study of Melanoma Risk in Australia and the United Kingdom
Study
phs000519
-
CIDR, NCI, NIDA Sequencing of Targeted Genomic Regions Associated with Smoking
Study
phs000813
-
Integration of Clinical and Molecular Biomarkers for Melanoma Survival (Berwick)
Study
phs003099
-
Successful Clinical Response in Pneumonia Therapy (SCRIPT)
Study
phs002300
-
Successful immune checkpoint blockade in a patient with advanced stage microsatellite unstable biliary tract cancer (H021)
Study
EGAS00001002441
-
Substantial somatic genomic variation and selection for BCOR mutations in human induced pluripotent stem cells
Dataset
EGAD00001007029
-
Alzheimer's Disease Sequencing Project (ADSP)
Study
phs000572
-
Lindsey E. Jones et al. Patient-derived cells from recurrent tumors that model the evolution of IDH-mutant glioma. Neuro-Oncology Advances, 2020. We established robust, versatile, and well-characterized Patient Derived Cells (PDC) of an IDH1-mutant astrocytoma and an IDH1-mutant oligodendroglioma that represents defined evolutionary stages of chemotherapy-induced hypermutation. The PDCs retain tumor subtype defining features over time as well as classic hallmarks of cancer, including anchorage independent growth and cell immortality. The integrated phylogenies composed of PDCs,single-cell-derived PDCs, patient-derived xenografts, and corresponding spatiotemporal tumor tissue samples also provide new insight into the clonality, evolutionary pattern, and immense mutational load of hypermutated IDH mutant gliomas.
Study
EGAS00001003992
-
eMERGE Network Phase III: HRC SNV and 1000 Genomes SV Imputed Array Data of 105,000 Participants
Study
phs001584
-
Research Program on Genes, Environment and Health (RPGEH)
Study
phs000788
-
MediMer: A versatile do-it-yourself peptide-receptive MHC class I multimer platform for tumor neoantigen-specific T cell detection
Study
EGAS50000000065
-
The NCAA-DoD Concussion Assessment, Research, and Education (CARE) Consortium
Study
phs002175
-
The Genetic Architecture of Smoking and Smoking Cessation
Study
phs000404
-
Institut Curie Neuroblastoma Whole Genome Sequencing Diagnosis Relapse
Study
EGAS00001001184
-
Institut Curie Neuroblastoma Whole Genome Sequencing Diagnosis Relapse
Dataset
EGAD00001001356
-
Transdisciplinary Studies of Genetic Variation in Colorectal Cancer(CORECT): Meta-analysis
Study
phs001499
-
Study of Addiction: Genetics and Environment (SAGE)
Study
phs000092
-
Clonal dynamics of normal haematopoiesis across the human lifespan
Dataset
EGAD00001007851
-
Development and Use of Network Infrastructure for High-Throughput GWA Studies
Study
phs000234
-
BC Cancer, part of the Provincial Health Services Authority, Technology Development Office, Data Access Committee (PHSA TDO DAC)
Dac
EGAC00000000011